Seeing Is Believing
EGRX is currently covered by 1 analysts with an average price target of $14.15. This is a potential upside of $13.27 (1507.95%) from yesterday's end of day stock price of $0.88.
Eagle Pharmaceuticals's activity chart (see below) currently has 70 price targets and 60 ratings on display. The stock rating distribution of EGRX is 100% SELL.
Analysts average stock forecasts to be materialized ratio is 78.09% with an average time for these price targets to be met of 170.2 days.
Highest price target for EGRX is $23, Lowest price target is $19, average price target is $17.
Most recent stock forecast was given by DAVID AMSELLEM from PIPER SANDLER on 09-Aug-2023. First documented stock forecast 10-Mar-2014.
Currently out of the existing stock ratings of EGRX, 1 are a SELL (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$17
$15.51 (1040.94%)
$31
1 years 7 months 21 days ago
(09-Aug-2023)
7/10 (70%)
$-2.23 (-11.60%)
64
Hold
$33
$31.51 (2114.77%)
$50
2 years 17 days ago
(13-Mar-2023)
3/4 (75%)
$7.49 (29.36%)
90
Buy
3 years 2 days ago
(28-Mar-2022)
1/1 (100%)
$46.76 (113.39%)
395
Buy
$57
3 years 11 months 23 days ago
(07-Apr-2021)
4/8 (50%)
$13.88 (32.19%)
168
Hold
$41
$25.23 (159.99%)
$52
6 years 8 days ago
(22-Mar-2019)
21/22 (95.45%)
$0.44 (0.83%)
134
What is EGRX (Eagle Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on EGRX (Eagle Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on EGRX (Eagle Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on EGRX (Eagle Pharmaceuticals)?
Which analyst is the currently most bullish on EGRX (Eagle Pharmaceuticals)?
Which analyst is the currently most reserved on EGRX (Eagle Pharmaceuticals)?